Key result
Diabetes linked to ~180% higher one-year mortality versus non-diabetics in standard post-MI cardiac rehabilitation.
Why the study?
Are standard cardiac rehabilitation programmes less effective for diabetic patients compared to non-diabetic patients following myocardial infarction?
Cohort (n=1,804)
No
Are standard cardiac rehabilitation programmes less effective for diabetic patients compared to non-diabetic patients following myocardial infarction?
Standard cardiac rehabilitation programs are less effective for diabetic patients post-MI, who experience higher mortality and lower rates of optimal medical therapy and lifestyle modifications.
Answers are grounded in this paper and cite their sources.
Excess mortality in diabetics despite CR attendance warrants caution; extends disparity data but leaves open whether tailored programs improve outcomes.
To assess clinical outcomes and lifestyle modifications in diabetic patients attending a standard cardiac rehabilitation programme following myocardial infarction (MI), a retrospective longitudinal study was undertaken in a district general hospital in the north west of England. A total of 1804 patients attended the cardiac rehabilitation programme over 10 years, of whom 223 (12.4%) had diabetes mellitus. Drugs were underprescribed in all patients, aspirin and beta-blockers especially in diabetics (75.3% vs 90.3%, p < 0.0001; 38.6% vs 60.8%, p < 0.0001). Smoking cessation was poor in diabetics (54.2% vs 69.1%, p < 0.003) and diabetics were less likely to attend at least one session of physiotherapy (26.9% vs 58.6%, p < 0.0001). Diabetics had higher mortality at one year (15.7% vs 5.6%; p < 0.0001), mostly associated with cardiovascular disease (13.4% vs 5.4%, p < 0.0001). Standard cardiac rehabilitation programmes appear to be less effective for patients with diabetes mellitus. We suggest that patients presenting with an existing chronic condition need specialised programmes of rehabilitation to integrate the care of that condition with their recent MI. Aggressive drug therapy following acute MI should also be prescribed in all patients when not contraindicated by other evidence.
No takes yet. Share an insight, caveat, or question.
Suresh et al. (2001) conducted a cohort in Myocardial infarction (n=1,804). Diabetes mellitus vs. Non-diabetics was evaluated on Mortality at one year (p=<0.0001). Diabetic patients attending standard cardiac rehabilitation following MI had higher one-year mortality compared to non-diabetics.
Synapse has enriched 10 related papers. Consider them for comparative context: